​

Adaptive Bio Ownership | Who Owns Adaptive Bio?

OverviewForecastRevenueFinancialsChartTranscripts

Adaptive Bio Ownership Summary

Adaptive Bio is owned by 97.00% institutional investors, 1.93% insiders, and 1.08% retail investors. Viking global investors lp is the largest institutional shareholder, holding 20.57% of ADPT shares. ARK Genomic Revolution is the top mutual fund, with 7.81% of its assets in Adaptive Bio shares.

ADPT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAdaptive Bio97.00%1.93%1.08%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Viking global investors lp29.99M20.57%$108.58M
Rubric capital management lp14.00M9.60%$50.68M
Blackrock11.66M8.00%$42.22M
Matrix capital management company, lp11.57M7.94%$41.89M
Ark investment management11.41M7.83%$41.31M
Vanguard group10.23M7.01%$37.02M
Millennium management9.26M6.35%$33.53M
Nikko asset management americas6.92M4.75%$24.98M
Sumitomo mitsui trust6.90M4.73%$24.98M
Massachusetts financial services co /ma/3.91M2.68%$14.16M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Rubric capital management lp14.00M1.33%$50.68M
Pier capital1.06M0.57%$3.82M
Soleus capital management1.72M0.55%$6.23M
Essex investment management623.83K0.42%$2.26M
Viking global investors lp29.99M0.42%$108.58M
Ark investment management11.41M0.37%$41.31M
Aristotle atlantic partners2.97M0.35%$10.77M
Ddd partners770.00K0.32%$2.79M
Matrix capital management company, lp11.57M0.32%$41.89M
Nikko asset management americas6.92M0.29%$24.98M

Top Buyers

HolderShares% AssetsChange
Millennium management9.26M0.02%8.43M
Rubric capital management lp14.00M1.33%3.50M
Soleus capital management1.72M0.55%1.72M
Massachusetts financial services co /ma/3.91M0.00%1.32M
Jane street group1.02M0.00%923.85K

Top Sellers

HolderShares% AssetsChange
Vanguard group10.23M0.00%-2.64M
Pictet asset management sa1.68M0.01%-1.82M
Blue water life science advisors, lp---1.69M
Braidwell lp---1.36M
Gilder gagnon howe---1.25M

New Positions

HolderShares% AssetsChangeValue
Soleus capital management1.72M0.55%1.72M$6.23M
Corebridge financial62.31K0.00%62.31K$225.57K
Mirae asset global etfs56.95K0.00%56.95K$206.14K
Canada pension plan investment board27.20K0.00%27.20K$98.46K
Vanguard personalized indexing management22.32K0.00%22.32K$80.82K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-24.00
Mather group, llc.-30.00
Assetmark-80.00
Avion wealth-139.00
Banque cantonale vaudoise-300.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20241866.29%143,084,242-3.73%960.93%965.49%44-4.35%
Jun 30, 2024174-8.90%148,628,4144.35%1011.07%915.81%45-31.82%
Mar 31, 2024191-4.50%142,434,185-0.71%970.99%86-11.34%66-7.04%
Dec 31, 20232005.26%143,448,1982.15%991.05%9727.63%71-2.74%
Sep 30, 2023190-10.38%140,422,1542.47%971.08%76-5.00%73-7.59%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
ARK Genomic Revolution11.52M7.81%243.77K
ARK Genomic Revolution ETF11.50M7.80%55.34K
Nikko AM ARK Pstv Chg Innovt P JPY Acc5.93M4.02%-72.07K
Vanguard Total Stock Mkt Idx Inv4.20M2.85%6.60K
iShares Russell 2000 ETF2.99M2.03%-6.73K
Nikko Gbl All Biological Genome Eq MF2.06M1.40%-121.82K
Vanguard Small Cap Index1.76M1.19%3.45K
Vanguard Institutional Extnd Mkt Idx Tr1.75M1.18%-25.48K
Pictet Biopharmaceutical Mother1.74M1.18%192.51K
MFS New Discovery I1.68M1.14%-

Recent Insider Transactions

DateNameRoleActivityValue
Nov 18, 2024PISKEL KYLE Chief Financial OfficerSell$1.24K
Aug 22, 2024Taylor Stacy L SVP and General CounselSell$121.08K
Mar 05, 2024PISKEL KYLE Principal Accounting OfficerSell$26.50K
Mar 05, 2024Taylor Stacy L SVP and General CounselSell$22.73K
Mar 05, 2024Taylor Stacy L SVP and General CounselSell$23.23K

Insider Transactions Trends

DateBuySell
2024 Q4-1
2024 Q3-1
2024 Q2--
2024 Q1-14
2023 Q4-1

ADPT Ownership FAQ

Who Owns Adaptive Bio?

Adaptive Bio shareholders are primarily institutional investors at 97.00%, followed by 1.93% insiders and 1.07% retail investors. The average institutional ownership in Adaptive Bio's industry, Biotech Stocks , is 47.04%, which Adaptive Bio exceeds.

Who owns the most shares of Adaptive Bio?

Adaptive Bio’s largest shareholders are Viking global investors lp (29.99M shares, 20.57%), Rubric capital management lp (14M shares, 9.60%), and Blackrock (11.66M shares, 8.00%). Together, they hold 38.18% of Adaptive Bio’s total shares outstanding.

Does Blackrock own Adaptive Bio?

Yes, BlackRock owns 8.00% of Adaptive Bio, totaling 11.66M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 42.22M$. In the last quarter, BlackRock increased its holdings by 473.88K shares, a 4.23% change.

Who is Adaptive Bio’s biggest shareholder by percentage of total assets invested?

Rubric capital management lp is Adaptive Bio’s biggest shareholder by percentage of total assets invested, with 1.33% of its assets in 14M Adaptive Bio shares, valued at 50.68M$.

Who is the top mutual fund holder of Adaptive Bio shares?

ARK Genomic Revolution is the top mutual fund holder of Adaptive Bio shares, with 7.81% of its total shares outstanding invested in 11.52M Adaptive Bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools